MedPath
NMPA Approval

Mifepristone Capsules

国药准字H20051435

January 22, 2024

Drug Information

米非司酮胶囊

碧韵

碧韵

胶囊剂

12.5mg

化学药品

January 22, 2024

Company Information

Applicant Company

武汉东湖新技术开发区光谷七路77号

Manufacturing Company

武汉东湖新技术开发区光谷七路77号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米非司酮胶囊 - NMPA 批准文号 | MedPath